Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2009

01-05-2009 | Brief Report

Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland

Authors: M. Wang, B. Yu, K. Westerlind, R. Strange, G. Khan, D. Patil, K. Boeneman, L. Hilakivi-Clarke

Published in: Breast Cancer Research and Treatment | Issue 1/2009

Login to get access

Abstract

Findings in BRCA1 mutation carriers suggest that physical activity, particularly during childhood, may be linked to a reduced risk of developing breast cancer. We investigated whether physical activity at puberty alters the expression of BRCA1 and two other tumor suppressor genes—p53 and estrogen receptor (ER)-β—in rats. In addition, the effects on ER-α expression, mammary proliferation and functional epithelial differentiation were investigated as markers of altered mammary cancer risk in rats exposed to regular physical activity at puberty. Female Sprague Dawley rat pups were randomized to voluntary exercise, sham-exercise control and non-manipulated control groups. Treadmill training (20–25 m/min, 15% grade, 30 min/day, 5 days/week) started on postnatal day 14 and continued through day 32. Third thoracic mammary glands (n = 5 per group and age) were obtained at days 32, 48 and 100 and assessed for changes in morphology through wholemounts, and at 100 days cell proliferation by using Ki67 staining, protein levels of ER-α and ER-β by immunohistochemistry, and mRNA expression levels of BRCA1, p53, ER-α and ER-β by real-time PCR. Mammary glands of rats exposed to exercise during puberty contained fewer terminal end buds (TEBs) and a higher number of differentiated alveolar buds and lobules than the sham controls. However, cell proliferation was not significantly altered among the groups. ER-α protein levels were significantly reduced, while ER-β levels were increased in the mammary ducts and lobular epithelial structures of 100-day old rays which were voluntarily exercised at puberty, compared to sham controls. ER-β, BRCA1 and p53 mRNA levels were significantly higher in the mammary glands of 100-day-old exercised versus sham control rats. Pubertal physical activity reduced mammary epithelial targets for neoplastic transformation through epithelial differentiation and it also up-regulated tumor suppressor genes BRCA1, p53 and ER-β, and reduced ER-α/ER-β ratio in the mammary gland. It remains to be determined whether the up-regulation of BRCA1, and perhaps p53, explains the protective effect of childhood physical activity against breast cancer in women who carry a germline mutation in one of the BRCA1 alleles.
Literature
5.
go back to reference McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F et al (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 14:1662–1677. doi:10.1038/oby.2006.191 CrossRef McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F et al (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 14:1662–1677. doi:10.​1038/​oby.​2006.​191 CrossRef
6.
go back to reference Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women : Exercise and premenopausal hormones. Cancer Causes Control 18:743–752. doi:10.1007/s10552-007-9017-5 PubMedCrossRef Tworoger SS, Missmer SA, Eliassen AH, Barbieri RL, Dowsett M, Hankinson SE (2007) Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women : Exercise and premenopausal hormones. Cancer Causes Control 18:743–752. doi:10.​1007/​s10552-007-9017-5 PubMedCrossRef
7.
go back to reference Margolis KL, Mucci L, Braaten T, Kumle M, Trolle LY, Adami HO et al (2005) Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women’s Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev 14:27–32PubMed Margolis KL, Mucci L, Braaten T, Kumle M, Trolle LY, Adami HO et al (2005) Physical activity in different periods of life and the risk of breast cancer: the Norwegian-Swedish Women’s Lifestyle and Health cohort study. Cancer Epidemiol Biomarkers Prev 14:27–32PubMed
9.
go back to reference Steindorf K, Schmidt M, Kropp S, Chang-Claude J (2003) Case-control study of physical activity and breast cancer risk among premenopausal women in Germany. Am J Epidemiol 157:121–130. doi:10.1093/aje/kwf181 PubMedCrossRef Steindorf K, Schmidt M, Kropp S, Chang-Claude J (2003) Case-control study of physical activity and breast cancer risk among premenopausal women in Germany. Am J Epidemiol 157:121–130. doi:10.​1093/​aje/​kwf181 PubMedCrossRef
11.
go back to reference Dobrovic A, Simpfendorfer D (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57:3347–3350PubMed Dobrovic A, Simpfendorfer D (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57:3347–3350PubMed
12.
go back to reference Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91:179–186. doi:10.1007/s10549-004-7603-8 PubMedCrossRef Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91:179–186. doi:10.​1007/​s10549-004-7603-8 PubMedCrossRef
13.
go back to reference Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der MR, Shyr Y, Holt JT, Moses HL, Jensen RA (2007) Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. Int J Biol Sci 3:281–291 Hoshino A, Yee CJ, Campbell M, Woltjer RL, Townsend RL, van der MR, Shyr Y, Holt JT, Moses HL, Jensen RA (2007) Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. Int J Biol Sci 3:281–291
14.
go back to reference Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ et al (1995) The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11:17–26. doi:10.1038/ng0995-17 PubMedCrossRef Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, Abel KJ et al (1995) The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11:17–26. doi:10.​1038/​ng0995-17 PubMedCrossRef
15.
go back to reference Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH (2005) Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11:931s–936sPubMed Russo J, Mailo D, Hu YF, Balogh G, Sheriff F, Russo IH (2005) Breast differentiation and its implication in cancer prevention. Clin Cancer Res 11:931s–936sPubMed
21.
go back to reference Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ et al (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252PubMed Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KJ et al (1997) Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families. Cancer Res 57:3245–3252PubMed
22.
go back to reference Kleihues P, Schauble B, Zur HA, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1–13PubMed Kleihues P, Schauble B, Zur HA, Esteve J, Ohgaki H (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 150:1–13PubMed
25.
go back to reference Sengupta S, Wasylyk B (2004) Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann N Y Acad Sci 1024:54–71. doi:10.1196/annals.1321.005 PubMedCrossRef Sengupta S, Wasylyk B (2004) Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann N Y Acad Sci 1024:54–71. doi:10.​1196/​annals.​1321.​005 PubMedCrossRef
26.
go back to reference Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244–278PubMed Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, van Zwieten MJ (1990) Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244–278PubMed
27.
go back to reference Russo J, Russo IH (1987) Biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112–137PubMed Russo J, Russo IH (1987) Biological and molecular bases of mammary carcinogenesis. Lab Invest 57:112–137PubMed
29.
go back to reference Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987–4991PubMed Clarke RB, Howell A, Potten CS, Anderson E (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57:4987–4991PubMed
32.
go back to reference Chang EC, Frasor J, Komm B, Katzenellenbogen BS (2006) Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147:4831–4842. doi:10.1210/en.2006-0563 PubMedCrossRef Chang EC, Frasor J, Komm B, Katzenellenbogen BS (2006) Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147:4831–4842. doi:10.​1210/​en.​2006-0563 PubMedCrossRef
33.
go back to reference Lin CY, Strom A, Li KS, Kietz S, Thomsen JS, Tee JB et al (2007) Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 9:R25. doi:10.1186/bcr1667 PubMedCrossRef Lin CY, Strom A, Li KS, Kietz S, Thomsen JS, Tee JB et al (2007) Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res 9:R25. doi:10.​1186/​bcr1667 PubMedCrossRef
35.
go back to reference Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman ME (1997) A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 94:9372–9377. doi:10.1073/pnas.94.17.9372 PubMedCrossRef Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman ME (1997) A maternal diet high in n-6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci USA 94:9372–9377. doi:10.​1073/​pnas.​94.​17.​9372 PubMedCrossRef
37.
go back to reference Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A et al (2007) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, Parrish A et al (2007) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene
38.
go back to reference Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43. doi:10.1038/8743 PubMedCrossRef Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T et al (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22:37–43. doi:10.​1038/​8743 PubMedCrossRef
40.
go back to reference Locke I, Kote-Jarai Z, Fackler MJ, Bancroft E, Osin P, Nerurkar A et al (2007) Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls. Breast Cancer Res 9:R20. doi:10.1186/bcr1657 PubMedCrossRef Locke I, Kote-Jarai Z, Fackler MJ, Bancroft E, Osin P, Nerurkar A et al (2007) Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls. Breast Cancer Res 9:R20. doi:10.​1186/​bcr1657 PubMedCrossRef
41.
go back to reference Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R (2007) HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis 28:299–309. doi:10.1093/carcin/bgl133 PubMedCrossRef Strathdee G, Sim A, Soutar R, Holyoake TL, Brown R (2007) HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia. Carcinogenesis 28:299–309. doi:10.​1093/​carcin/​bgl133 PubMedCrossRef
42.
go back to reference Meng ZH, Ben Y, Li Z, Chew K, Ljung BM, Lagios MD et al (2004) Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization. Genes Chromosomes Cancer 41:214–222. doi:10.1002/gcc.20089 PubMedCrossRef Meng ZH, Ben Y, Li Z, Chew K, Ljung BM, Lagios MD et al (2004) Aberrations of breast cancer susceptibility genes occur early in sporadic breast tumors and in acquisition of breast epithelial immortalization. Genes Chromosomes Cancer 41:214–222. doi:10.​1002/​gcc.​20089 PubMedCrossRef
Metadata
Title
Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland
Authors
M. Wang
B. Yu
K. Westerlind
R. Strange
G. Khan
D. Patil
K. Boeneman
L. Hilakivi-Clarke
Publication date
01-05-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0062-x

Other articles of this Issue 1/2009

Breast Cancer Research and Treatment 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine